Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management of cytokine release syndrome: an update on emerging antigen-specific T cell engaging immunotherapies

Published:2019-07 Issue:10 Volume:11 Page:851-857
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Khadka Roman H¹²,Sakemura Reona³,Kenderian Saad S²³,Johnson Aaron J²⁴

Affiliation:

1. Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA

2. Department of Immunology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA

3. Division of Hematology, Mayo Clinic, Rochester, MN 55905, USA

4. Department of Neurology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt-2019-0074

Reference22 articles.

1. Chimeric antigen receptor T-cell therapy — assessment and management of toxicities

2. The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy

3. Recent advances of bispecific antibodies in solid tumors

4. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

5. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology;European Journal of Heart Failure;2024-08

2. Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy;Advances in Cancer Immunotherapy [Working Title];2024-05-15

3. Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study;Leukemia & Lymphoma;2024-05-07

4. A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma;Cancer Immunology, Immunotherapy;2024-04-20

5. Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions;Frontiers in Pharmacology;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3